Plain-English translation of NCT02872987 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The GMALL Registry is a long-term tracking study that collects information about how adults with acute lymphoblastic leukemia (ALL) and related blood cancers are diagnosed, treated, and how they respond to treatment. Researchers gather medical data and blood or tissue samples from patients receiving standard care to better understand these diseases and improve future treatments. Whether you're enrolled in a specific clinical trial or receiving routine care, your information helps build knowledge for the entire medical community.
Acute lymphoblastic leukemia is a serious blood cancer, and doctors need better ways to diagnose, treat, and predict outcomes for patients. By collecting real-world information from many patients over time, researchers can identify patterns, improve existing treatments, and develop new ones.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect and review your medical information—such as test results, imaging scans, and treatment details—as part of your routine care. You would also be asked to donate blood or tissue samples at certain time points. There is no separate treatment you must take; instead, this registry tracks your existing medical care and outcomes over time, making it a way to contribute to research while you receive the care you already need.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Austria
Germany